G01N2333/90638 - CPC Classification Index

ClassID:

170590 ⎘

G01N2333/90638 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) acting on the CH-NH group of donors (1.4) with oxygen as acceptor (1.4.3) in general with a definite EC number (1.4.3.-)

Recent Application in this class:

20250115883

2025-04-10

RECOMBINANTLY EXPRESSED GLUTAMATE OXIDASE

20240076711

2024-03-07

IDENTIFICATION OF MITOCHONDRIA-ENRICHED CELLS

20230349907

2023-11-02

BIOPROBES FOR LYSYL OXIDASES AND USES THEREOF

20230104758

2023-04-06

COMPOUNDS AND METHODS FOR AMINE OXIDASE IMAGING

20220047531

2022-02-17

Energy drinks and other nutritional aids derived from agave-based spirits

20210310042

2021-10-07

SAMPLING METHOD AND KIT FOR HISTAMINE MEASUREMENT

20200087700

2020-03-19

Biosensor for multi-analyte characterization

20190231717

2019-08-01

Energy drinks and other nutritional aids derived from agave-based spirits

20190072514

2019-03-07

SYSTEM AND METHOD FOR DETECTING LYSYL OXIDASE-LIKE 2 PROTEIN (LOXL2) AND BREAST CANCER

#10

20190048382

2019-02-14

Biosensor for multi-analyte characterization

#11

20180340204

2018-11-29

Neuro-chemical sensor with selectively permeable membrane on nano-electrode

#12

20180340203

2018-11-29

Neuro-chemical sensor with selectively permeable membrane on nano-electrode

#13

20180155447

2018-06-07

METHODS FOR TREATING CARDIOVASCULAR DISEASES

#14

20180071388

2018-03-15

Use of VAP-1 inhibitors for treating fibrotic conditions

#15

20170327595

2017-11-16

THERAPEUTIC AND DIAGNOSTIC METHODS RELATED TO LYSYL OXIDASE-LIKE 2 (LOXL2)

#16

20170226559

2017-08-10

Markers for mood disorders

#17

20170059504

2017-03-02

Detection module and method for operating the same

#18

20160319248

2016-11-03

Fructose amino acid oxidase, preparation method and enzyme-containing kit for detecting glycated albumin

#19

20160222128

2016-08-04

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

#20

20160161508

2016-06-09

METHOD FOR DIAGNOSING NEURO-DEGENERATIVE DISEASE

#21

20160074343

2016-03-17

Energy drinks and other nutritional aids derived from agave-based spirits

#22

20160002610

2016-01-07

Modified glycine oxidase

#23

20150361182

2015-12-17

METHODS FOR TREATING CARDIOVASCULAR DISEASES

#24

20150346212

2015-12-03

SYSTEM FOR DETECTION OF A COMPONENT IN A FLUID

#25

20150253280

2015-09-10

System and method for detecting lysyl oxidase-like 2 protein (LOXL2) and breast cancer

#26

20150247870

2015-09-03

Method for aiding diagnosis of Alzheimer's disease

#27

20150044199

2015-02-12

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

#28

20140377791

2014-12-25

Two-photon absorbing compound with methods of synthesis and use

#29

20130195883

2013-08-01

Use of VAP-1 inhibitors for treating fibrotic conditions

#30

20130022617

2013-01-24

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

#31

20120283127

2012-11-08

Diagnostic method for Alzheimer's disease

#32

20120014939

2012-01-19

Methods and compositions for the treatment and diagnosis of haemorrhagic conversion

#33

20110067123

2011-03-17

MAO-B ELEVATION AS AN EARLY PARKINSON'S DISEASE BIOMARKER

#34

20100317721

2010-12-16

Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis

#35

20080318229

2008-12-25

Method for Diagnosing Neuro-Degenerative Disease